...
首页> 外文期刊>Journal of medicinal food >Antihyperlipidemic Activity of Ligularia fischeri Extract in Mice Fed a High-Carbohydrate Diet
【24h】

Antihyperlipidemic Activity of Ligularia fischeri Extract in Mice Fed a High-Carbohydrate Diet

机译:小鼠中的Ligularia Fischeri提取物的抗高疫脂活性喂养高碳水化合物饮食

获取原文
获取原文并翻译 | 示例
           

摘要

Ligularia fischeri, indigenous to eastern Asia, has been used as a traditional herbal medicine. Ligularia fischeri reportedly possesses a number of biological activities such as antimutagenic, antioxidant, antigenotoxic, and anti-inflammation. This study demonstrated the effects of ethanol extracts of Ligularia fischeri (ELF) on a high-carbohydrate diet (HCD)-induced hyperlipidemia in C57BL/6 mice. The mice were divided into six groups (n = 7/group) as follows: normal diet, HCD, or HCD+ELF (100, 200, 400, and 800 mg/kg/day), which were orally administered daily for 12 weeks. Various lipid parameters and histological changes in liver and fat tissue were compared among the treatment and control groups. ELF remarkably reduced body weight gain and attenuated hyperlipidemia by improving the plasma levels of total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, atherogenic index, and cardiac risk factor. Moreover, ELF decreased the HCD-induced hepatic accumulation of lipid droplets and adipocyte hypertrophy. These regulatory effects of ELF appeared to be mediated through the phosphorylation of AMP-activated protein kinase, acetyl-CoA carboxylase, sterol regulatory element-binding protein-1c, and expression of fatty acid synthase. Taken together, these findings indicate a functional role for ELF in the regulation of HCD-induced obesity and hyperlipidemia.
机译:Ligularia fischeri,土着到东亚,已被用作传统的草药。据报道,Ligularia Fischeri拥有许多生物学活性,如抗微生物,抗氧化剂,抗原毒性和抗炎。本研究表明,乙醇提取物对高碳水化合物饮食(HCD)的高碳水化合物饮食(HCD) - 诱导的C57BL / 6小鼠诱导的高脂血症。将小鼠分为六组(n = 7 /组),如下:正常饮食,HCD或HCD + ELF(100,200,400和800mg / kg /天),每天口服施用12周。在治疗和对照组中比较了各种脂质参数和肝脏和脂肪组织的组织学变化。通过改善总胆固醇,甘油三酯,高密度脂蛋白胆固醇,低密度脂蛋白胆固醇,动脉根茎指数和心脏病危险因子的血浆水平显着降低体重增加和减毒的高脂血症。此外,ELF降低了HCD诱导的脂液滴和脂肪细胞肥大的肝积累。这些ELF的调节效果似乎通过AMP活化蛋白激酶,乙酰-COA羧化酶,甾醇调节元素结合蛋白-1C的磷酸化介导,以及脂肪酸合酶的表达。在一起,这些发现表明ELF在监管HCD诱导的肥胖症和高脂血症中的功能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号